Bespoke Extracts (BSPK) Equity Average (2011 - 2025)
Bespoke Extracts' (BSPK) quarterly Equity Average came in at -$2.6 million in Q3 2025, down 14.07% year-on-year from -$3.0 million in Q3 2024, and down 5.36% quarter-over-quarter from -$2.4 million in Q2 2025.
Bespoke Extracts (BSPK) Equity Average (2011 - 2025) Analysis & Trends
Bespoke Extracts has disclosed Equity Average across 15 years of filings, most recently posting -$2.6 million for Q3 2025.
- Equity Average for Q3 2025 came in at -$2.6 million, down 14.07% year-over-year; the trailing twelve-month figure through Sep 2025 was -$2.6 million (down 14.07% YoY), and the FY2024 annual result was -$1.9 million, down 59.24% from the prior year.
- Equity Average came in at -$2.6 million for Q3 2025 at Bespoke Extracts, down from -$2.4 million in the prior quarter.
- In the past five years, Equity Average ranged from a high of $1.9 million in Q2 2022 to a low of -$2.6 million in Q3 2025.
- The 5-year median for Equity Average is -$1.2 million (2023), against an average of -$871659.3.
- Across the five-year window, Equity Average surged 67.77% in 2021 and sank 473.55% in 2023, its largest moves.
- Bespoke Extracts' Equity Average stood at -$248983.0 in 2021, then surged by 276.24% to $438811.0 in 2022, then tumbled by 473.55% to -$1.6 million in 2023, then tumbled by 34.87% to -$2.2 million in 2024, then decreased by 16.14% to -$2.6 million in 2025.
- The last three Equity Average figures came in at -$2.6 million (Q3 2025), -$2.4 million (Q2 2025), and -$2.2 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 8.07 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 3.32 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 6.50 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 409.63 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 3.33 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 6.52 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 1.79 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 493.55 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.15 Bn |
| 10 | Bespoke Extracts | - | - | 234,175.00 | -2.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -2.57 Mn |
| Jun 30, 2025 | -2.44 Mn |
| Mar 31, 2025 | -2.21 Mn |
| Dec 31, 2024 | -2.21 Mn |
| Sep 30, 2024 | -2.25 Mn |
| Jun 30, 2024 | -2.07 Mn |
| Mar 31, 2024 | -1.85 Mn |
| Dec 31, 2023 | -1.64 Mn |
| Sep 30, 2023 | -1.45 Mn |
| Jun 30, 2023 | -1.16 Mn |
| Mar 31, 2023 | -821,190.00 |
| Dec 31, 2022 | 438,811.00 |
| Sep 30, 2022 | 1.69 Mn |
| Jun 30, 2022 | 1.91 Mn |
| Mar 31, 2022 | 953,439.50 |
| Nov 30, 2021 | -248,983.00 |
| Aug 31, 2021 | -343,877.50 |
| May 31, 2021 | -119,727.50 |
| Feb 28, 2021 | -167,856.50 |
| Nov 30, 2020 | -439,718.00 |